Series A Companies in Cambridge

Camena Bioscience is a synthetic biology company that develops tools to engineer new synthetic biology applications.

Luminopia develops a new class of treatments for significant neuro-visual disorders.

Rgenta Therapeutics develops a pipeline of oral, small-molecule RNA-targeting medicines with an initial focus on oncology.

A Social Multiplayer Games Studio

Watershed Informatics catalyzes discovery by democratizing access to bioinformatics tools for biologists.

Mediar is a pre-clinical stage biotechnology company developing therapeutics for the treatment of fibrosis.

Poplar Therapeutics anti-IgE therapy treats atopic diseases such as food allergy, allergic asthma, and atopic dermatitis.

Prudentia Sciences is a platform enables AI-powered Asset Diligence and Valuation to De-Risk Investment in Drug Development.

AvengeBio is focusing on Cell-Generated Immunotherapies to eradicate solid tumors.

Kirontech uses cutting edge machine learning technology to revolutionize the use of healthcare data.

Cellular Origins is an automation manufacturing company that provides cell and gene therapies.

Sunlight.Io develops products that virtualize any high-performance workload with bare-metal performance.

Abselion is the biological sensor for rapid and cost-effective detection of biological substances.

Neutrolis is a candidate-stage company advancing its first-in-class therapies that target Neutrophil Extracellular Traps (NETs).

DataQube is the developer of 5G enabled edge data centre.

Liquid AI develops artificial intelligence solutions for data analysis and decision-making across various industries.

Montai Health platform enables rapid and repeatable advancement of therapies across multiple diseases.

Tutor Intelligence builds AI-driven warehouse robots that handle picking, packing, and material-handling operations.

Nu Quantum focuses on developing quantum networking hardware and software to scale quantum computers for practical use.

Caldera Therapeutics is a biotech company engaged in the development of bispecific antibody CLD-423 for inflammatory bowel disease (IBD).

HC Bioscience is an innovator and pioneer of protein editing using context agnostic engineered tRNA.

Parthenon Therapeutics is a biotech company inventing a novel class of anti-cancer therapies that reprogram the tumor microenvironment.

Clade Therapeutics discovers and delivers next-generation cell medicines to improve the lives of patients.

Obrizum is the true adaptive learning and analytics platform using AI to transform proprietary content into workforce capability.

Pramana is a manufacturer of digital pathology solutions specializing in the development of fully autonomous image scanning systems.